These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8604621)

  • 61. Comparison of safety and efficacy of bivalirudin versus unfractionated heparin in high-risk patients undergoing percutaneous coronary intervention (from the Anti-Thrombotic Strategy for Reduction of Myocardial Damage During Angioplasty-Bivalirudin vs Heparin study).
    Patti G; Pasceri V; D'Antonio L; D'Ambrosio A; Macrì M; Dicuonzo G; Colonna G; Montinaro A; Di Sciascio G
    Am J Cardiol; 2012 Aug; 110(4):478-84. PubMed ID: 22583760
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Low-dose heparin for routine coronary angioplasty and stenting.
    Vainer J; Fleisch M; Gunnes P; Ramamurthy S; Garachemani A; Kaufmann UP; Meyer BJ; Lüscher TF; Meier B
    Am J Cardiol; 1996 Oct; 78(8):964-6. PubMed ID: 8888679
    [No Abstract]   [Full Text] [Related]  

  • 63. What is the optimal anticoagulation level with argatroban during percutaneous coronary intervention?
    Cruz-Gonzalez I; Sanchez-Ledesma M; Osakabe M; Watanabe H; Baron SJ; Healy JL; Yeh RW; Jang IK
    Blood Coagul Fibrinolysis; 2008 Jul; 19(5):401-4. PubMed ID: 18600089
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Safety of low dose heparin in elective coronary angioplasty.
    Koch KT; Piek JJ; de Winter RJ; David GK; Mulder K; Tijssen JG; Lie KI
    Heart; 1997 Jun; 77(6):517-22. PubMed ID: 9227294
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Laboratory monitoring of heparin and the combination of heparin and the platelet glycoprotein IIb/IIIa receptor antibody fragment abciximab (c7E3) in patients undergoing percutaneous transluminal coronary angioplasty (PTCA).
    Zahn R; Haubelt H; Bechtloff S; Schneider S; Frilling B; Rustige J; Marsalek P; Seidl K; Senges J; Hellstern P
    Herz; 2003 Aug; 28(5):445-52. PubMed ID: 12928744
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new regimen for heparin use in acute coronary syndromes.
    Hochman JS; Wali AU; Gavrila D; Sim MJ; Malhotra S; Palazzo AM; De La Fuente B
    Am Heart J; 1999 Aug; 138(2 Pt 1):313-8. PubMed ID: 10426845
    [TBL] [Abstract][Full Text] [Related]  

  • 67. New frontiers in the management of unstable coronary artery disease.
    Turpie AG
    Am J Cardiol; 1997 Sep; 80(5A):21E-24E. PubMed ID: 9296465
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) 11B trial.
    Antman EM; McCabe CH; Gurfinkel EP; Turpie AG; Bernink PJ; Salein D; Bayes De Luna A; Fox K; Lablanche JM; Radley D; Premmereur J; Braunwald E
    Circulation; 1999 Oct; 100(15):1593-601. PubMed ID: 10517729
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.
    Topol EJ; Fuster V; Harrington RA; Califf RM; Kleiman NS; Kereiakes DJ; Cohen M; Chapekis A; Gold HK; Tannenbaum MA
    Circulation; 1994 Apr; 89(4):1557-66. PubMed ID: 8149521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy and safety of bivalirudin versus heparins in reduction of cardiac outcomes in acute coronary syndrome and percutaneous coronary interventions.
    Singh S; Molnar J; Arora R
    J Cardiovasc Pharmacol Ther; 2007 Dec; 12(4):283-91. PubMed ID: 18172222
    [TBL] [Abstract][Full Text] [Related]  

  • 72. A case of acute coronary artery occlusion associated with very rapid onset heparin-induced thrombosis without thrombocytopenia.
    Hondo T; Matsumura H; Matsuda K; Iwamoto A; Eno S; Kimura M
    Intern Med; 2012; 51(6):607-11. PubMed ID: 22449669
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Effectiveness of heparin in preventing thrombin generation and thrombin activity in patients undergoing coronary intervention.
    Ragosta M; Karve M; Brezynski D; Humphries J; Sanders JM; Sarembock IJ; Gimple LW; Powers ER
    Am Heart J; 1999 Feb; 137(2):250-7. PubMed ID: 9924158
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Adjunctive intracoronary urokinase therapy during percutaneous transluminal coronary angioplasty.
    Schächinger V; Kasper W; Zeiher AM
    Am J Cardiol; 1996 Jun; 77(14):1174-8. PubMed ID: 8651091
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B; Micheli A; Picchi A; Bandinelli L; Brizi MG; Severi S; Limbruno U
    Coron Artery Dis; 2009 Aug; 20(5):348-53. PubMed ID: 19543084
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization.
    EPILOG Investigators
    N Engl J Med; 1997 Jun; 336(24):1689-96. PubMed ID: 9182212
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Accounting for ACUITY.
    Bittl JA
    N Engl J Med; 2006 Nov; 355(21):2249-50. PubMed ID: 17124024
    [No Abstract]   [Full Text] [Related]  

  • 78. Antiplatelet therapy in therapy-resistant unstable angina. A pilot study with REO PRO (c7E3).
    van den Brand MJ; Simoons ML; de Boer MJ; van Miltenburg A; van der Wieken LR; de Feyter PJ
    Eur Heart J; 1995 Nov; 16 Suppl L():36-42. PubMed ID: 8869017
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Determination of markers of activation of the coagulation system in patients with unstable angina pectoris during heparin therapy].
    Riabysh EV; Dobrovil'skiĭ AB; Staroverov II
    Klin Lab Diagn; 2005 Jun; (6):43-5. PubMed ID: 16078533
    [No Abstract]   [Full Text] [Related]  

  • 80. Cases of Brainstem Infarcts after Cessation of Heparin Treatment: is it a Rebound Effect?
    Demir CF; Surgun F; Ozdemir H; Kapan O
    Eurasian J Med; 2011 Dec; 43(3):186-8. PubMed ID: 25610190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.